clopidogrel and phenyl acetate

clopidogrel has been researched along with phenyl acetate in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kaluza, G; Kleiman, NS; Mazur, W	1
Chen, X; Gao, W; Jing, J; Li, N; Lu, Y; Parekha, HS; Qiu, Z; Ren, S; Song, L; Tian, F; Wang, X	1
Backman, JT; Filppula, AM; Itkonen, MK; Neuvonen, M; Neuvonen, PJ; Niemi, M; Tornio, A	1
Choi, Y; Nguyen, TVT; Park, HS; Shin, YS; Suh, DH; Trinh, HKT	1

Reviews

1 review(s) available for clopidogrel and phenyl acetate

Article	Year
Antiplatelet therapy for treatment of acute coronary syndromes. Cardiology clinics, 1999, Volume: 17, Issue:2 Topics: Abciximab; Acetates; Antibodies, Monoclonal; Aspirin; Clopidogrel; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine; Vascular Patency	1999

Trials

1 trial(s) available for clopidogrel and phenyl acetate

Article	Year
Clopidogrel but Not Prasugrel Significantly Inhibits the CYP2C8-Mediated Metabolism of Montelukast in Humans. Clinical pharmacology and therapeutics, 2018, Volume: 104, Issue:3 Topics: Acetates; Adult; Clopidogrel; Computer Simulation; Cross-Over Studies; Cyclopropanes; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C8 Inhibitors; Drug Interactions; Female; Healthy Volunteers; Humans; Inactivation, Metabolic; Leukotriene Antagonists; Male; Models, Biological; Oxidation-Reduction; Pharmacogenetics; Pharmacogenomic Variants; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Quinolines; Risk Assessment; Substrate Specificity; Sulfides; Young Adult	2018

Article

Year

Clopidogrel but Not Prasugrel Significantly Inhibits the CYP2C8-Mediated Metabolism of Montelukast in Humans.

Clinical pharmacology and therapeutics, 2018, Volume: 104, Issue:3

Topics: Acetates; Adult; Clopidogrel; Computer Simulation; Cross-Over Studies; Cyclopropanes; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C8 Inhibitors; Drug Interactions; Female; Healthy Volunteers; Humans; Inactivation, Metabolic; Leukotriene Antagonists; Male; Models, Biological; Oxidation-Reduction; Pharmacogenetics; Pharmacogenomic Variants; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Quinolines; Risk Assessment; Substrate Specificity; Sulfides; Young Adult

2018

Other Studies

3 other study(ies) available for clopidogrel and phenyl acetate

Article	Year
[New antiplatelet agents]. Investigacion clinica, 2000, Volume: 41, Issue:3 Topics: Abciximab; Acetates; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clopidogrel; Cyclooxygenase Inhibitors; Dipyridamole; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Ticlopidine; Tirofiban; Tyrosine	2000
Contributions of intestine and plasma to the presystemic bioconversion of vicagrel, an acetate of clopidogrel. Pharmaceutical research, 2014, Volume: 31, Issue:1 Topics: Acetates; Animals; Clopidogrel; Esterases; Humans; Hydrolysis; Intestinal Mucosa; Microsomes; Phenylacetates; Prodrugs; Rats; Rats, Sprague-Dawley; Thiophenes; Ticlopidine	2014
Characterization of cysteinyl leukotriene-related receptors and their interactions in a mouse model of asthma. Prostaglandins, leukotrienes, and essential fatty acids, 2019, Volume: 141 Topics: Acetates; Animals; Asthma; Clopidogrel; Cyclohexanecarboxylic Acids; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Eosinophils; Female; Inflammation; Interleukins; Leukotriene Antagonists; Mice; Mice, Inbred BALB C; Ovalbumin; Phthalic Acids; Purinergic P2Y Receptor Antagonists; Quinolines; Receptors, Leukotriene; Receptors, Purinergic P2Y12; Sulfides; Th2 Cells	2019